Case Western Reserve University School of Medicine, Cleveland, Ohio.
University Hospitals of Cleveland, Cleveland, Ohio.
J Clin Sleep Med. 2024 Jan 1;20(1):135-149. doi: 10.5664/jcsm.10832.
This multisociety commentary critically examines the Agency for Healthcare Research and Quality (AHRQ) final report and systematic review on long-term health outcomes in obstructive sleep apnea. The AHRQ report was commissioned by the Centers for Medicare & Medicaid Services and particularly focused on the long-term patient-centered outcomes of continuous positive airway pressure, the variability of sleep-disordered breathing metrics, and the validity of these metrics as surrogate outcomes. This commentary raises concerns regarding the AHRQ report conclusions and their potential implications for policy decisions. A major concern expressed in this commentary is that the AHRQ report inadequately acknowledges the benefits of continuous positive airway pressure for several established, long-term clinically important outcomes including excessive sleepiness, motor vehicle accidents, and blood pressure. While acknowledging the limited evidence for the long-term benefits of continuous positive airway pressure treatment, especially cardiovascular outcomes, as summarized by the AHRQ report, this commentary reviews the limitations of recent randomized controlled trials and nonrandomized controlled studies and the challenges of conducting future randomized controlled trials. A research agenda to address these challenges is proposed including study designs that may include both high quality randomized controlled trials and nonrandomized controlled studies. This commentary concludes by highlighting implications for the safety and quality of life for the millions of people living with obstructive sleep apnea if the AHRQ report alone was used by payers to limit coverage for the treatment of obstructive sleep apnea while not considering the totality of available evidence.
Patil SP, Billings ME, Bourjeily G, et al. Long-term health outcomes for patients with obstructive sleep apnea: placing the Agency for Healthcare Research and Quality report in context-a multisociety commentary. . 2024;20(1):135-149.
本文批判性地审查了医疗保健研究与质量局 (AHRQ) 关于阻塞性睡眠呼吸暂停长期健康结果的最终报告和系统评价。AHRQ 报告是由医疗保险和医疗补助服务中心委托编写的,特别关注持续气道正压通气的长期以患者为中心的结果、睡眠呼吸障碍指标的可变性,以及这些指标作为替代结果的有效性。本文对 AHRQ 报告的结论及其对政策决策的潜在影响表示担忧。本文评论中表达的一个主要关切是,AHRQ 报告没有充分承认持续气道正压通气对几个已确立的、长期重要的临床结果的益处,包括过度嗜睡、机动车事故和血压。虽然承认 AHRQ 报告总结的持续气道正压通气治疗长期益处的证据有限,特别是心血管结果,但本文评论了最近随机对照试验和非随机对照研究的局限性,以及开展未来随机对照试验的挑战。提出了一个解决这些挑战的研究议程,包括可能包括高质量随机对照试验和非随机对照研究的研究设计。本文最后强调了如果仅使用 AHRQ 报告来限制阻塞性睡眠呼吸暂停治疗的覆盖范围,而不考虑现有证据的全貌,这将对数百万患有阻塞性睡眠呼吸暂停的人的安全和生活质量产生影响。